Interview with Carlos Apellaniz, Healthcare Partner, Korn/Ferry Mexico
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
Address: Montes Urales 505, 3rd Floor Lomas de Chapultepec Del. Miguel Hidalgo 11000 Mexico DF ,Mexico
Tel: 55 5095 9500
Web: http://https//www.kornferry.com/
Since our inception, clients have trusted Korn/Ferry to help them recruit world-class leadership talent. Building on this heritage, today we are a single source for a wide range of leadership and talent consulting services. From our nearly 80 offices in 40 countries, we assist organizations in attracting, engaging, developing, and retaining their people. Services range from executive recruitment to leadership development programs, enterprise learning, succession planning and recruitment outsourcing.
As one of the world’s top ranked leadership and talent consulting firms, we build more effective people, teams, and organizations to drive accelerated business results, and achieve sustainable change. We work with Boards, CEOs, CHROs, and CLOs to align their talent strategy with their business strategy — bringing together deep consulting expertise with the most advanced research-validated methodologies available. Our goal is to transform the lives of the people and organizations we serve, and the worldwide leadership and talent industry.
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge…
Can you tell us a little about the history of Medix and about the company itself? Medix is a 100% Mexican company created in 1956, and our major strength is…
Apotex has increased production, launched 16 new products last March, and grown significantly in the market. What would you say has been the biggest change in the market over the…
The last time we interviewed you was in 2008. Please can you tell our readers a little bit more about Liomont’s growth drivers and changes over these last four years?…
When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how…
Please can you tell our readers a little bit more about the history of Stendhal, and its major milestones along the way since its takeover in 1997? Stendhal is a…
Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”.…
Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this acquisition affect Nycomed’s Latin…
The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory…
There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local plant rule. COFEPRIS has…
This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we last interviewed you in 2008?…
This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now we’re delighted to be…
See our Cookie Privacy Policy Here
